Cancers | Free Full-Text | Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas
Prognostic value of NUCB2 protein expression for the BCR-free survival... | Download Table
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study | Leukemia
Quantitative measurement of BCR/abl transcripts usingreal-time polymerase chain reaction - Annals of Oncology
PDF] Chronic Myeloid Leukemia--Prognostic Value of Mutations. | Semantic Scholar
Treatment schedule for BCR-ABL-positive ALL in the JALSG ALL202 study | Download Table
Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG) | Haematologica
Incidence, characteristics and risk factors of thromboembolic events in East Asian patients with BCR-ABL1 negative myeloproliferative neoplasms | Scientific Reports
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review - European Urology
Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic–Phase Chronic Myeloid Leukemia - Clinical Lymphoma, Myeloma and Leukemia
Response by baseline BCR-ABL mutation analysis | Download Table
Adherence and clinical responses with BCR-ABL1 TKI treatment. 56-62 | Download Table
PDF] BCR-ABL rearrangement frequencies in chronic myeloid leukemia and acute lymphoblastic leukemia in Ecuador, South America. | Semantic Scholar
Table 3 from Prognostic Implication of BCR-ABL Fusion Transcript Variants in Chronic Myeloid Leukemia (CML) Treated with Imatinib. A First of Its Kind Study on CML Patients of Kashmir | Semantic Scholar
Frontiers | BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
The clinicopathological significance and prognostic value of programmed death-ligand 1 in prostate cancer: a meta-analysis of 3133 patients | Aging
Prognostic value of NUCB2 protein expression for the BCR-free survival... | Download Table
Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology
Spectrum of BCR-ABL Mutations and Treatment Outcomes in Ethiopian Imatinib-Resistant Patients With Chronic Myeloid Leukemia | JCO Global Oncology
PDF] Frequency of p190 and p210 BCR-ABL rearrangements and survival in Brazilian adult patients with acute lymphoblastic leukemia | Semantic Scholar
Table 1 from Prognostic value of subclassification (pT2 stage) of pathologically organ-confined prostate cancer: Confirmation of the changes introduced in the 8th edition of the American Joint Committee on Cancer (AJCC) staging
One-Pot Identification of BCR/ABLp210 Transcript Isoforms Based on Nanocluster Beacon | ACS Sensors
The International Scale for reporting BCR-ABL1 transcript levels. | Download Scientific Diagram
Identification of microenvironment related potential biomarkers of biochemical recurrence at 3 years after prostatectomy in prostate adenocarcinoma | Aging
Standardization of BCR-ABL1 quantification on the international scale in China using locally developed secondary reference panels - Experimental Hematology
Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemia - ScienceDirect
Table 1 from Prognostic Implication of BCR-ABL Fusion Transcript Variants in Chronic Myeloid Leukemia (CML) Treated with Imatinib. A First of Its Kind Study on CML Patients of Kashmir | Semantic Scholar